QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
NYSE:TAK

Takeda Pharmaceutical (TAK) News Today

$16.21
+0.09 (+0.56%)
(As of 06/9/2023 ET)
Compare
Today's Range
$16.16
▼
$16.28
50-Day Range
$15.84
▼
$17.11
52-Week Range
$12.28
▼
$17.15
Volume
1.64 million shs
Average Volume
2.48 million shs
Market Capitalization
$51.30 billion
P/E Ratio
21.05
Dividend Yield
1.67%
Price Target
$24.67
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media
Get Takeda Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter.



TAK Media Mentions By Week

TAK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TAK
News Sentiment
▼
0.26

0.70
▲
Average
Medical
News Sentiment

TAK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TAK Articles
This Week
▼
5

5
▲
TAK Articles
Average Week

SourceHeadline
marketbeat.com logoTFG Asset Management GP Ltd Grows Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)
marketbeat.com - June 9 at 5:29 PM
benzinga.com logoEnhancing Care: Expansion of Alpers Disease Treatment Market Size On its Path to US$ 1.90 Billion by 2030, at a 4.57% of CAGR.
benzinga.com - June 7 at 2:10 PM
marketbeat.com logoUBS Group AG Reduces Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)
marketbeat.com - June 7 at 4:36 AM
marketbeat.com logoTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Acquired by Schechter Investment Advisors LLC
marketbeat.com - June 6 at 11:20 AM
MarketBeat logoTakeda Pharmaceutical Company Limited (NYSE:TAK) Given Consensus Recommendation of "Moderate Buy" by Brokerages
americanbankingnews.com - June 6 at 5:52 AM
finance.yahoo.com logoThe area's largest life sciences employer, Takeda keeps reinventing itself
finance.yahoo.com - June 2 at 7:48 AM
marketbeat.com logoTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Sold by Causeway Capital Management LLC
marketbeat.com - May 31 at 1:50 PM
marketbeat.com logoRaymond James & Associates Boosts Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)
marketbeat.com - May 30 at 4:42 AM
marketbeat.com logoClal Insurance Enterprises Holdings Ltd Boosts Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)
marketbeat.com - May 29 at 10:38 AM
bizjournals.com logoThis drug could help children with brain cancer. What's taken it so long?
bizjournals.com - May 26 at 7:34 PM
finance.yahoo.com logoTakeda to Present Oncology Portfolio and Pipeline Data at the 2023 ASCO Annual Meeting and EHA Congress
finance.yahoo.com - May 26 at 9:33 AM
marketbeat.com logoO Shaughnessy Asset Management LLC Cuts Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)
marketbeat.com - May 26 at 7:46 AM
finance.yahoo.com logoTakeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review
finance.yahoo.com - May 25 at 6:14 PM
fool.com logoTakeda Pharmaceutical (NYSE: TAK)
fool.com - May 25 at 7:59 AM
benzinga.com logoGovernment of Japan Expresses its Pledge of US$200 Million to GHIT Fund/UNDP Replenishment
benzinga.com - May 25 at 2:16 AM
finance.yahoo.com logoReasons to Add Puma (PBYI) Stock to Your Portfolio Right Now
finance.yahoo.com - May 22 at 4:14 PM
marketwatch.com logo2023 Dipeptidyl Peptidase-4 Inhibitors Market Size and Insight Report in Pharma & Healthcare Sector | with [100 Pages] and Forecast till 2031
marketwatch.com - May 17 at 4:08 PM
marketwatch.com logoAxial Spondyloarthritis Market Analysis by Size, Share, Trends, Emerging Trends, Qualitative Outlook and Worldwide Forecast to 2030
marketwatch.com - May 17 at 9:27 AM
marketbeat.com logoMercer Global Advisors Inc. ADV Grows Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)
marketbeat.com - May 17 at 6:27 AM
MarketBeat logoTakeda Pharmaceutical Company Limited (NYSE:TAK) Receives Consensus Recommendation of "Moderate Buy" from Analysts
americanbankingnews.com - May 17 at 2:58 AM
marketwatch.com logo2023-2030 Blow-Fill-Seal (BFS) Technology Market: Highlights with Growth Rate
marketwatch.com - May 17 at 1:26 AM
benzinga.com logoGlobal Blood Cancer Drugs Market Report 2023: Increasing Prevalence of Blood Cancer Cases Drives Growth
benzinga.com - May 16 at 8:26 PM
finance.yahoo.com logoTakeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2022 Earnings Call Transcript
finance.yahoo.com - May 16 at 3:26 PM
benzinga.com logoTargeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
benzinga.com - May 15 at 2:19 PM
MarketBeat logoTakeda Pharmaceutical (NYSE:TAK) Issues FY 2023 Earnings Guidance
americanbankingnews.com - May 15 at 7:44 AM
marketbeat.com logoTakeda Pharmaceutical Company Limited (NYSE:TAK) Receives Average Rating of "Moderate Buy" from Brokerages
marketbeat.com - May 12 at 7:28 PM
marketbeat.com logoTakeda Pharmaceutical (NYSE:TAK) Releases FY 2023 Earnings Guidance
marketbeat.com - May 12 at 1:04 PM
msn.com logoTakeda FY22 sales grow but FY23 outlook weighed down by generic impact
msn.com - May 11 at 4:56 PM
finance.yahoo.com logoTakeda Moves Out From Licensing Agreement With Theravance Biopharma
finance.yahoo.com - May 11 at 4:56 PM
marketwatch.com logoTakeda Pharmaceutical 4Q Rev Y960.00B, Given Y3.07T Rev in Preceding 9 Mos, WSJ Calculation Shows>4502.TO
marketwatch.com - May 11 at 3:54 AM
finance.yahoo.com logoTakeda Delivers Strong Revenue and Profit Growth in FY2022; Updated Capital Allocation Policy Reflects Deleveraging Progress and Confidence in Growth Outlook
finance.yahoo.com - May 11 at 3:54 AM
finance.yahoo.com logoTakeda Presents Real-World Clinical Effectiveness and Safety Results of Vedolizumab (ENTYVIO®) and Ustekinumab as First-Line Biologic Treatment for Crohn's Disease
finance.yahoo.com - May 10 at 7:51 AM
bizjournals.com logoTakeda to lay off up to 186 employees in Massachusetts
bizjournals.com - May 8 at 5:59 PM
marketbeat.com logoTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Acquired by Envestnet Asset Management Inc.
marketbeat.com - May 8 at 5:42 AM
marketwatch.com logo2030 Pericarditis Drugs Market Forecast: Positive Growth Trajectory Ahead
marketwatch.com - May 5 at 9:30 PM
marketbeat.com logoParallel Advisors LLC Reduces Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)
marketbeat.com - May 5 at 4:52 AM
marketwatch.com logoLipid Metabolism Disease Market Size and Forecast till 2031
marketwatch.com - May 4 at 10:38 AM
marketwatch.com logoNarcolepsy Treatment Market Demand Overview, Growth Innovation, Latest Trends till 2029- Teva Pharmaceutical, Takeda, Jazz Pharmaceuticals
marketwatch.com - May 3 at 9:46 AM
marketwatch.com logoMarine Pharmaceuticals Market SWOT Analysis, Sales, Revenue, Price and Gross Margin 2023-2030 Seattle Genetics, DSM, Eisai Co
marketwatch.com - May 2 at 9:56 AM
marketbeat.com logoJanney Montgomery Scott LLC Decreases Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)
marketbeat.com - April 30 at 4:27 AM
marketwatch.com logoBlow Fill Seal (BFS) Market Share by 2030
marketwatch.com - April 29 at 9:13 AM
msn.com logo3 Biotech Buyout Targets to Watch
msn.com - April 29 at 9:13 AM
marketwatch.com logoAntihypertensive Market Complete Overview till 2031
marketwatch.com - April 28 at 7:58 PM
marketwatch.com logoNarcolepsy Therapeutics Market Overview and Scope By 2030
marketwatch.com - April 28 at 7:58 PM
marketbeat.com logoTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Purchased by Managed Asset Portfolios LLC
marketbeat.com - April 28 at 1:55 PM
marketwatch.com logoEpilepsy Therapeutics Market Research Analysis 2023-2031
marketwatch.com - April 28 at 1:01 AM
finance.yahoo.com logoTakeda Announces FDA Acceptance of BLA Resubmission for Investigational Subcutaneous Administration of Entyvio® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis
finance.yahoo.com - April 27 at 9:45 AM
marketbeat.com logoHeritage Investors Management Corp Decreases Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)
marketbeat.com - April 27 at 8:36 AM
finanznachrichten.de logoCorza Medical Inc.: Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations
finanznachrichten.de - April 26 at 9:26 AM
finance.yahoo.com logoLiver Diseases Therapeutics Global Market Report 2023
finance.yahoo.com - April 26 at 9:26 AM
Get Takeda Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NYSE:TAK) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -